There are 3397 resources available
LBA49 - mRNA-4157 (V940) individualized neoantigen therapy + pembrolizumab vs pembrolizumab in high-risk resected melanoma: Clinical efficacy and correlates of response
Presenter: Jeffrey Weber
Session: Proffered Paper session - Melanoma and other skin tumours
Resources:
Abstract
Slides
Webcast
CN28 - From difficulty to meaning: Palliative cancer patients experience on advance care planning conversation and having a palliative plan
Presenter: Adriana Kolstrøm
Session: EONS16: Person centred care in cancer
Resources:
Abstract
Preventive strategies for chemotherapy-induced peripheral neuropathy (CIPN)
Presenter: Sebastian Nielsen
Session: Cancer-related central and peripheral neuropathy
Resources:
Slides
Webcast
Therapy at relapse
Presenter: Laurie Sehn
Session: Diffuse large B-cell lymphoma
Resources:
Slides
Webcast
Horizon scanning of emerging therapeutics in the next decade: What does the future hold?
Presenter: Dario Trapani
Session: ESMO-WHO review of innovation in cancer therapeutics: Does the pipeline meet the need?
Resources:
Slides
Webcast
The role of surgery
Presenter: Giulia Veronesi
Session: Management of oligometastatic disease in NSCLC
Resources:
Slides
Webcast
Invited Discussant 552O and LBA27
Presenter: Dominik Modest
Session: Proffered Paper session 2 - Gastrointestinal tumours, lower digestive
Resources:
Slides
Webcast
Invited Discussant 853O and 857O
Presenter: Silke Tribius
Session: Proffered Paper session - Head and neck cancer
Resources:
Slides
Webcast
PARP inhibition
Presenter: Elena Castro
Session: Molecular targets and related treatments
Resources:
Slides
Webcast
Personalised medicine and targeted agents for biliary tract cancer
Presenter: Lorenza Rimassa
Session: How to navigate the different treatment options for hepatobiliary cancers
Resources:
Slides
Webcast